Welcome to our dedicated page for NIDEC ADR news (Ticker: $NJDCY), a resource for investors and traders seeking the latest updates and insights on NIDEC ADR stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NIDEC ADR's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NIDEC ADR's position in the market.
Nidec announced the status of its own share repurchase plan under the Companies Act of Japan. The company repurchased 0 shares for 0 yen during the period from April 1, 2024, through April 30, 2024. The total number of shares that may be repurchased is up to 2,000,000 shares with a total repurchasable amount of 11 billion yen.